呼吸指南

订阅

MedSci主页 / 所有栏目 / 呼吸指南

2020 ERS声明：慢性血栓栓塞性肺动脉高压

2020-12-17 欧洲呼吸学会 Eur Respir J . 2020 Dec 17;2002828.

肺动脉高压

2020年12月，欧洲呼吸学会(ERS)发布了慢性血栓栓塞性肺动脉高压管理声明，慢性血栓栓塞性肺动脉高压（CTEPH）是一种罕见的急性肺栓塞并发症，本文概述了当前关于CTEPH诊治相关文献和实践，主要

中文标题：

2020 ERS声明：慢性血栓栓塞性肺动脉高压

英文标题：

ERS Statement on Chronic Thromboembolic Pulmonary Hypertension

发布机构：

欧洲呼吸学会

发布日期：

2020-12-17

简要介绍：

2020年12月，欧洲呼吸学会(ERS)发布了慢性血栓栓塞性肺动脉高压管理声明，慢性血栓栓塞性肺动脉高压（CTEPH）是一种罕见的急性肺栓塞并发症，本文概述了当前关于CTEPH诊治相关文献和实践，主要内容涉及CTEPH的定义、诊断，流行病学、随访、病理生理学、肺动脉内膜切除治疗。球囊肺血管成形术，药物以及联合治疗、康复管理等。

 

相关资料下载：
[AttachmentFileName(sort=1, fileName=2020 ERS声明：慢性血栓栓塞性肺动脉高压.pdf)] GetToolGuiderByIdResponse(projectId=1, id=5f2581c00203234d, title=2020 ERS声明：慢性血栓栓塞性肺动脉高压, enTitle=ERS Statement on Chronic Thromboembolic Pulmonary Hypertension, guiderFrom=Eur Respir J . 2020 Dec 17;2002828., authorId=0, author=, summary=2020年12月，欧洲呼吸学会(ERS)发布了慢性血栓栓塞性肺动脉高压管理声明，慢性血栓栓塞性肺动脉高压（CTEPH）是一种罕见的急性肺栓塞并发症，本文概述了当前关于CTEPH诊治相关文献和实践，主要, cover=https://img.medsci.cn/20201230/1609259043629_2020535.jpg, journalId=0, articlesId=null, associationId=172, associationName=欧洲呼吸学会, associationIntro=欧洲呼吸学会（ERS）是欧洲专业学会组织，是具有广泛基础的拥有100多个国家的大约一万名成员。内容涵盖了基础科学和临床医学。, copyright=0, guiderPublishedTime=Thu Dec 17 00:00:00 CST 2020, originalUrl=, linkOutUrl=, content=<div class="one_info2" style="color: #373737;"> <div id="all_content"> <div class="editor_mirror editor_mirror_del"> <p>2020年12月，欧洲呼吸学会(ERS)发布了慢性血栓栓塞性肺动脉高压管理声明，慢性血栓栓塞性肺动脉高压（CTEPH）是一种罕见的急性肺栓塞并发症，本文概述了当前关于CTEPH诊治相关文献和实践，主要内容涉及CTEPH的定义、诊断，流行病学、随访、病理生理学、肺动脉内膜切除治疗。球囊肺血管成形术，药物以及联合治疗、康复管理等。</p> </div> </div> </div> <div class="box_info" style="color: #373737;">&nbsp;</div>, tagList=[TagDto(tagId=1179, tagName=肺动脉高压)], categoryList=[CategoryDto(categoryId=12, categoryName=呼吸, tenant=100), CategoryDto(categoryId=85, categoryName=指南&解读, tenant=100), CategoryDto(categoryId=21100, categoryName=达仁堂循证e学界, tenant=100)], articleKeywordId=0, articleKeyword=, articleKeywordNum=6, guiderKeywordId=1179, guiderKeyword=肺动脉高压, guiderKeywordNum=6, haveAttachments=1, attachmentList=null, guiderType=0, guiderArea=, guiderLanguage=0, guiderRegion=3, opened=0, paymentType=, paymentAmount=0, recommend=0, recommendEndTime=null, sticky=0, stickyEndTime=null, allHits=3926, appHits=392, showAppHits=0, pcHits=1316, showPcHits=3534, likes=0, shares=16, comments=19, approvalStatus=1, publishedTime=Wed Dec 30 00:24:21 CST 2020, publishedTimeString=2020-12-17, pcVisible=1, appVisible=1, editorId=2020535, editor=qiushida2, waterMark=0, formatted=0, memberCards=[], isPrivilege=0, deleted=0, version=2, createdBy=null, createdName=qiushida2, createdTime=Wed Dec 30 00:24:09 CST 2020, updatedBy=2020535, updatedName=qiushida2, updatedTime=Sat Jan 06 14:49:29 CST 2024, courseDetails=[], otherVersionGuiders=[], isGuiderMember=false, ipAttribution=, attachmentFileNameList=[AttachmentFileName(sort=1, fileName=2020 ERS声明：慢性血栓栓塞性肺动脉高压.pdf)])
2020 ERS声明：慢性血栓栓塞性肺动脉高压.pdf
下载请点击：
评论区 (16)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1066267, encodeId=b0d6106626e2b, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055279, encodeId=c51e10552e91f, content=想看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46445576118, createdName=枫语Lily, createdTime=Mon Sep 27 10:11:08 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006800, encodeId=a890100680064, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210414/74acf51dc67c4905b857b73fdb80f145/1204a71866c844d49799244c743c6cf5.jpg, createdBy=47ee5419152, createdName=ms4000000651155070, createdTime=Tue Aug 10 23:17:45 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958932, encodeId=4c6595893227, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TJ7gPf6xictpXAFXHs9s1kC197L4IPz0GvDqjUvofcCkHGFrbnlo0PicFvZybRNRxpMEiaO3EgCvLCj5r5LvETrxQ/132, createdBy=0c372474384, createdName=QYYI, createdTime=Tue Apr 20 23:30:19 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956774, encodeId=68d0956e74a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b605442151, createdName=ms4000001975205411, createdTime=Wed Apr 14 01:37:55 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-11-02 taken110

    好资源，想学习

    0

  2. [GetPortalCommentsPageByObjectIdResponse(id=1066267, encodeId=b0d6106626e2b, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055279, encodeId=c51e10552e91f, content=想看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46445576118, createdName=枫语Lily, createdTime=Mon Sep 27 10:11:08 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006800, encodeId=a890100680064, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210414/74acf51dc67c4905b857b73fdb80f145/1204a71866c844d49799244c743c6cf5.jpg, createdBy=47ee5419152, createdName=ms4000000651155070, createdTime=Tue Aug 10 23:17:45 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958932, encodeId=4c6595893227, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TJ7gPf6xictpXAFXHs9s1kC197L4IPz0GvDqjUvofcCkHGFrbnlo0PicFvZybRNRxpMEiaO3EgCvLCj5r5LvETrxQ/132, createdBy=0c372474384, createdName=QYYI, createdTime=Tue Apr 20 23:30:19 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956774, encodeId=68d0956e74a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b605442151, createdName=ms4000001975205411, createdTime=Wed Apr 14 01:37:55 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-09-27 枫语Lily

    想看原文

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1066267, encodeId=b0d6106626e2b, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055279, encodeId=c51e10552e91f, content=想看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46445576118, createdName=枫语Lily, createdTime=Mon Sep 27 10:11:08 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006800, encodeId=a890100680064, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210414/74acf51dc67c4905b857b73fdb80f145/1204a71866c844d49799244c743c6cf5.jpg, createdBy=47ee5419152, createdName=ms4000000651155070, createdTime=Tue Aug 10 23:17:45 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958932, encodeId=4c6595893227, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TJ7gPf6xictpXAFXHs9s1kC197L4IPz0GvDqjUvofcCkHGFrbnlo0PicFvZybRNRxpMEiaO3EgCvLCj5r5LvETrxQ/132, createdBy=0c372474384, createdName=QYYI, createdTime=Tue Apr 20 23:30:19 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956774, encodeId=68d0956e74a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b605442151, createdName=ms4000001975205411, createdTime=Wed Apr 14 01:37:55 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-08-10 ms4000000651155070

    学习了

    0

  4. [GetPortalCommentsPageByObjectIdResponse(id=1066267, encodeId=b0d6106626e2b, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055279, encodeId=c51e10552e91f, content=想看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46445576118, createdName=枫语Lily, createdTime=Mon Sep 27 10:11:08 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006800, encodeId=a890100680064, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210414/74acf51dc67c4905b857b73fdb80f145/1204a71866c844d49799244c743c6cf5.jpg, createdBy=47ee5419152, createdName=ms4000000651155070, createdTime=Tue Aug 10 23:17:45 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958932, encodeId=4c6595893227, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TJ7gPf6xictpXAFXHs9s1kC197L4IPz0GvDqjUvofcCkHGFrbnlo0PicFvZybRNRxpMEiaO3EgCvLCj5r5LvETrxQ/132, createdBy=0c372474384, createdName=QYYI, createdTime=Tue Apr 20 23:30:19 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956774, encodeId=68d0956e74a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b605442151, createdName=ms4000001975205411, createdTime=Wed Apr 14 01:37:55 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-04-20 QYYI

    谢谢

    0

  5. [GetPortalCommentsPageByObjectIdResponse(id=1066267, encodeId=b0d6106626e2b, content=好资源，想学习, beContent=null, objectType=guider, channel=null, level=null, likeNumber=52, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/H3QXYibjbzM9C5GELMGhjqMatvmOsXy5gzoqIT6XJqYYCg7BqyfaLVW7gmk0bjAUJygFZUxt3XakaHUP7VIGDww/132, createdBy=a1285314326, createdName=taken110, createdTime=Tue Nov 02 15:55:13 CST 2021, time=2021-11-02, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1055279, encodeId=c51e10552e91f, content=想看原文, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=46445576118, createdName=枫语Lily, createdTime=Mon Sep 27 10:11:08 CST 2021, time=2021-09-27, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1006800, encodeId=a890100680064, content=学习了, beContent=null, objectType=guider, channel=null, level=null, likeNumber=55, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20210414/74acf51dc67c4905b857b73fdb80f145/1204a71866c844d49799244c743c6cf5.jpg, createdBy=47ee5419152, createdName=ms4000000651155070, createdTime=Tue Aug 10 23:17:45 CST 2021, time=2021-08-10, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=958932, encodeId=4c6595893227, content=谢谢, beContent=null, objectType=guider, channel=null, level=null, likeNumber=61, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=http://thirdwx.qlogo.cn/mmopen/vi_32/TJ7gPf6xictpXAFXHs9s1kC197L4IPz0GvDqjUvofcCkHGFrbnlo0PicFvZybRNRxpMEiaO3EgCvLCj5r5LvETrxQ/132, createdBy=0c372474384, createdName=QYYI, createdTime=Tue Apr 20 23:30:19 CST 2021, time=2021-04-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=956774, encodeId=68d0956e74a3, content=好, beContent=null, objectType=guider, channel=null, level=null, likeNumber=64, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=4b605442151, createdName=ms4000001975205411, createdTime=Wed Apr 14 01:37:55 CST 2021, time=2021-04-14, status=1, ipAttribution=)]
    2021-04-14 ms4000001975205411

    好

    0

以上为热门评论，梅斯医学App还有更多内容

相关指南

2020 CCS/CTS立场声明：肺动脉高压

加拿大心血管学会(CCS,Canadian Cardiovascular Society) · 2020-07-15

2018 TSOC指南：肺动脉高压的诊断和治疗（更新版）

台湾心脏病学会(TSOC,Taiwan Society of Cardiology) · 2019-03-26

2018 CHEST指南：成人肺动脉高压的治疗

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2019-01-14

2018 科隆共识会议建议：成人先天性心脏病患者肺动脉高压

国外心血管相关专家小组（统称） · 2018-08-25

2018 科隆共识会议建议：肺动脉高压的定义，临床分类和初始诊断

国外呼吸科专家组（统称） · 2018-08-27

新生儿肺动脉高压诊治专家共识

中华医学会儿科学分会新生儿学组 · 2017-03-30

拓展阅读

2011AHA 大面积和次大面积肺栓塞、髂股深静脉血栓形成以及慢性血栓栓塞性肺动脉高压的治疗指南

美国心脏协会(AHA,American Heart Association) · 2011-04-21

先天性心脏病相关肺动脉高压中国专家共识

中华医学会心血管病学分会(Chinese Society of Cardiology) · 2012-12-01

2013先天性心脏病相关性肺动脉高压诊治专家共识

中国心血管病相关专家小组（统称） · 2013-05-16

2014 肺动脉高压治疗流程

中国呼吸科专家组（统称） · 2014-01-02

2014 ATS临床实践指南：美国镰状细胞贫血患者肺动脉高压的诊断危险分层和管理

美国胸科学会(ATS,American Thoracic Society) · 2014-03-15

2014 ACCP成人肺动脉高压药物治疗指南

美国胸科医师学会(ACCP,American College of Chest Physicians) · 2014-06-17